Medicare Enrolled
Dr. Amaiak Chilingaryan, M.D.
Neurology · Glendale, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chilingaryan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chilingaryan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chilingaryan
Dr. Amaiak Chilingaryan is a neurology specialist in Glendale, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Chilingaryan performed 5,874 Medicare services across 2,135 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chilingaryan received a total of $27,560 from 80 pharmaceutical and/or device companies across 1082 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chilingaryan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 14% volume in CA
$27,560 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,874
Medicare services
Top 14% in CA for neurology
2,135
Unique beneficiaries
$110
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~392 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
2,599 | $66 | $100 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
814 | $153 | $300 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
552 | $88 | $200 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
399 | $100 | $133 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
244 | $109 | $172 |
| New patient office visit, complex (60-74 min) | 234 | $188 | $400 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
153 | $188 | $350 |
| Digital analysis of brain wave activity (EEG) This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision. |
138 | $250 | $456 |
| EEG brain wave test, 61-119 minutes This procedure measures electrical activity in the brain using electrodes placed on the scalp. It records brain wave patterns for a duration between 61 and 119 minutes. |
129 | $395 | $800 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 88 | $236 | $350 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
79 | $82 | $256 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
79 | $156 | $400 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
77 | $145 | $400 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
60 | $47 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
50 | $143 | $250 |
| Head repositioning exercises for dizziness A series of exercises performed to reposition the head, used to treat dizziness. The procedure is administered on a daily basis. |
36 | $37 | $100 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
27 | $219 | $350 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
26 | $4 | $50 |
| Positive pressure ventilator therapy A therapy procedure that uses a positive pressure ventilator to assist with breathing. |
22 | $56 | $100 |
| Smoking cessation counseling, more than 10 minutes Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes. |
21 | $29 | $100 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
20 | $64 | $250 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
15 | $41 | $120 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
12 | $253 | $450 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$27,560
Total received (2018-2024)
Avg $3,937/year across 7 years
Top 13% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
80
Companies
1,082
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,170 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$390 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,084
2023
$5,538
2022
$5,160
2021
$3,785
2020
$2,835
2019
$2,510
2018
$1,648
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$1,023
EMD Serono, Inc.
$413
Lundbeck LLC
$372
SK Life Science, Inc.
$364
ABBVIE INC.
$332
Neurelis, Inc.
$315
ACADIA Pharmaceuticals Inc
$311
ARGENX US, INC.
$310
MDD US Operations, LLC
$268
Lilly USA, LLC
$234
Abbott Laboratories
$199
Amneal Pharmaceuticals LLC
$196
Alexion Pharmaceuticals, Inc.
$186
Celgene Corporation
$166
Neurocrine Biosciences, Inc.
$157
Novartis Pharmaceuticals Corporation
$149
Teva Pharmaceuticals USA, Inc.
$131
Otsuka America Pharmaceutical, Inc.
$126
Kyowa Kirin, Inc.
$85
ANI Pharmaceuticals, Inc.
$84
Biogen, Inc.
$76
PFIZER INC.
$71
SCILEX PHARMACEUTICALS INC.
$63
Vanda Pharmaceuticals Inc.
$59
Eisai Inc.
$56
GlaxoSmithKline, LLC.
$45
IDORSIA PHARMACEUTICALS US INC
$44
CATALYST PHARMACEUTICALS, INC.
$35
MITSUBISHI TANABE PHARMA AMERICA, INC.
$31
GE HEALTHCARE
$30
CSL Behring
$30
LivaNova USA, Inc.
$27
Grifols USA, LLC
$23
Sumitomo Pharma America, Inc.
$19
Mallinckrodt Hospital Products Inc.
$19
Alnylam Pharmaceuticals Inc.
$19
Currax Pharmaceuticals LLC
$17
Top 3 companies account for 29.7% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$2,288
Teva Pharmaceuticals USA, Inc.
$1,638
SK Life Science, Inc.
$1,525
ACADIA Pharmaceuticals Inc
$1,300
EMD Serono, Inc.
$1,146
Avanir Pharmaceuticals, Inc.
$1,040
Lundbeck LLC
$867
Novartis Pharmaceuticals Corporation
$851
Biogen, Inc.
$843
Amneal Pharmaceuticals LLC
$803
Alexion Pharmaceuticals, Inc.
$765
Sunovion Pharmaceuticals Inc.
$752
Alnylam Pharmaceuticals Inc.
$695
ARGENX US, INC.
$669
GENZYME CORPORATION
$666
ABBVIE INC.
$645
Neurocrine Biosciences, Inc.
$607
Acorda Therapeutics, Inc
$595
AbbVie Inc.
$515
Lilly USA, LLC
$508
Celgene Corporation
$479
Kyowa Kirin, Inc.
$446
MDD US Operations, LLC
$426
Supernus Pharmaceuticals, Inc.
$411
Neurelis, Inc.
$401
Amgen Inc.
$397
Abbott Laboratories
$361
GlaxoSmithKline, LLC.
$347
Otsuka America Pharmaceutical, Inc.
$340
Eisai Inc.
$324
LivaNova USA, Inc.
$289
Adamas Pharmaceuticals, Inc.
$272
CSL Behring
$246
Corium, LLC
$183
Greenwich Biosciences, Inc.
$174
Boston Scientific Corporation
$173
Allergan, Inc.
$164
Grifols USA, LLC
$149
Biohaven Pharmaceuticals, Inc.
$148
Sumitomo Pharma America, Inc.
$142
Bausch Health US, LLC
$138
Biohaven Pharmaceutical Holding Company Ltd.
$138
PFIZER INC.
$135
Banner Life Sciences, LLC
$133
Janssen Pharmaceuticals, Inc
$128
Takeda Pharmaceuticals U.S.A., Inc.
$127
Medtronic USA, Inc.
$125
Merck Sharp & Dohme LLC
$121
US WorldMeds, LLC
$110
IDORSIA PHARMACEUTICALS US INC
$104
Catalyst Pharmaceuticals, Inc.
$102
CATALYST PHARMACEUTICALS, INC.
$102
Merck Sharp & Dohme Corporation
$98
GE Healthcare
$94
Collegium Pharmaceutical, Inc.
$86
Currax Pharmaceuticals LLC
$85
ANI Pharmaceuticals, Inc.
$84
AstraZeneca Pharmaceuticals LP
$84
Almatica Pharma LLC
$78
MITSUBISHI TANABE PHARMA AMERICA, INC.
$77
Medtronic, Inc.
$72
Scilex Pharmaceuticals Inc.
$69
SCILEX PHARMACEUTICALS INC.
$63
Vanda Pharmaceuticals Inc.
$59
JAZZ PHARMACEUTICALS INC.
$57
IMPEL PHARMACEUTICALS INC.
$54
BANNER LIFE SCIENCES, LLC
$50
EISAI INC.
$49
Promius Pharma LLC
$47
Strongbridge US INC.
$43
Horizon Therapeutics plc
$40
Impax Laboratories, Inc.
$35
Xeris Pharmaceuticals, Inc.
$33
RedHill Biopharma Inc.
$32
GE HEALTHCARE
$30
Cala Health, Inc.
$24
Mallinckrodt Hospital Products Inc.
$19
ARBOR PHARMACEUTICALS, INC.
$19
Bayer HealthCare Pharmaceuticals Inc.
$12
Vertical Pharmaceuticals, LLC
$12
Top 3 companies account for 19.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPLATZER · AMPLATZER Occluders · AMPYRA · AMVUTTRA · AMYVID · ANORO · ANORO ELLIPTA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BELSOMRA · BRILINTA · Betaseron · Briviact · CALA TRIO · CONTRAVE · COPAXONE · CREXONT · Cenobamate · DUOPA · Dayvigo · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · EXSERVAN · Epidiolex · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Gocovri · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LATUDA · LINQ II · LOREEV XR · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · ONGENTYS · ONPATTRO · ONZETRA XSAIL · OSMOLEX ER · OXTELLAR XR · Ongentys · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · TECFIDERA · TRELEGY ELLIPTA · TROKENDI XR · TYSABRI · Talicia · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WATCHMAN · XADAGO · XCOPRI · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
548
Per 100K population
5.6
County median income
$87,760
Nearest hospital
GLENDALE MEM HOSPITAL & HLTH CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chilingaryan is a clinical cardiology specialist, with above-average Medicare volume (top 14% in CA), with low-engagement industry engagement in the top 13% of CA peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chilingaryan experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Chilingaryan performed 2,599 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chilingaryan receive payments from pharmaceutical companies?
Yes. Dr. Chilingaryan received a total of $27,560 from 80 companies across 1,082 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chilingaryan's costs compare to other neurologists in Glendale?
Dr. Chilingaryan's average Medicare payment per service is $110. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chilingaryan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Glendale
Browse neurologists in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
SK Life Science, Inc. Payments to Doctors
See all physicians who received payments from SK Life Science, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology